Alkacen 2 mg Tablets

Melphalan belongs to a class of chemotherapy medications known as alkylating agents, which work by attaching to and damaging the DNA within cancer cells, preventing them from properly replicating and dividing. This disruption ultimately leads to the destruction of rapidly dividing cancer cells, helping slow disease progression. It is commonly used in the treatment of multiple myeloma, a cancer affecting plasma cells in the bone marrow, often as part of a combination treatment regimen alongside other medications like corticosteroids. Melphalan is also used in certain cases of ovarian cancer and as part of high-dose conditioning regimens before stem cell transplantation for various blood cancers. The tablets are taken orally, with dosing carefully individualized based on the specific condition being treated, treatment phase, and the patient's overall health status. Regular monitoring, including blood counts, is an essential part of treatment to help track the body's response and guide any necessary dose adjustments. Many patients experience meaningful disease control and improved outcomes as part of a comprehensive treatment plan involving Melphalan. Close follow-up with an experienced oncology or hematology care team supports the best possible treatment results. As with all chemotherapy medications, Melphalan tablets should be used strictly under the guidance of a healthcare provider experienced in treating the specific condition..